Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Narcolepsy

Recruiting

Investigational

Phase 3 Study of Pitolisant for Excessive Daytime Sleepiness in Narcolepsy Patients

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Pitolisant

Contact Research Centre

Asthma

Recruiting

Registered drugNo placebo

Safety and Tolerability of Benralizumab in Patients with HES, EGPA, or Asthma Who Completed a Prior Study

Registered drugNo placebo

Belgium

Participants:0–17 years · 18–64 years · 65+ years
Substances:Benralizumab

Contact Research Centre

Study of JNJ-78934804 (guselkumab and golimumab) versus guselkumab in adults with moderately to severely active Crohn’s disease

Recruiting

InvestigationalNo placebo

Study of JNJ-78934804 (guselkumab and golimumab) versus guselkumab in adults with moderately to severely active Crohn’s disease

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Golimumab

Contact Research Centre

Narcolepsy

Recruiting

Investigational

Efficacy and Safety of ALKS 2680 and Alixorexton in Adults with Narcolepsy Type 1

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Alks 2680

Contact Research Centre

Small cell lung cancer

Recruiting

Registered drugNo placebo

Phase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Topotecan Hydrochloride

Contact Research Centre

Narcolepsy

Recruiting

Investigational

Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 2

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Alks 2680

Contact Research Centre

Narcolepsy

Recruiting

Investigational

Phase 3 Randomized Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 1

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Alks 2680

Contact Research Centre

Chronic obstructive pulmonary disease

Recruiting

Registered drug

A study to evaluate the efficacy and safety of depemokimab and salbutamol sulfate in patients with chronic obstructive pulmonary disease and type 2 inflammation.

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Depemokimab

Contact Research Centre

Metabolic dysfunction-associated steatohepatitis+1

Recruiting

Investigational

A Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:BI 456906

Contact Research Centre

Metabolic dysfunction-associated steatohepatitis+1

Recruiting

Investigational

A Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:BI 456906

Contact Research Centre

Chronic spontaneous urticaria

Recruiting

Registered drugNo placebo

A study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Barzolvolimab

Contact Research Centre

Pancreatic neuroendocrine tumour

Recruiting

Registered drugNo placebo

A study comparing XL092 versus everolimus in patients with previously treated advanced or metastatic neuroendocrine tumors

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Everolimus

Contact Research Centre

Find therapies in clinical trials near you

507 trials match your criteria

Narcolepsy

Phase 3 Study of Pitolisant for Excessive Daytime Sleepiness in Narcolepsy Patients

Asthma

Safety and Tolerability of Benralizumab in Patients with HES, EGPA, or Asthma Who Completed a Prior Study

Study of JNJ-78934804 (guselkumab and golimumab) versus guselkumab in adults with moderately to severely active Crohn’s disease

Study of JNJ-78934804 (guselkumab and golimumab) versus guselkumab in adults with moderately to severely active Crohn’s disease

Narcolepsy

Efficacy and Safety of ALKS 2680 and Alixorexton in Adults with Narcolepsy Type 1

Small cell lung cancer

Phase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer

Narcolepsy

Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 2

Narcolepsy

Phase 3 Randomized Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 1

Chronic obstructive pulmonary disease

A study to evaluate the efficacy and safety of depemokimab and salbutamol sulfate in patients with chronic obstructive pulmonary disease and type 2 inflammation.

Metabolic dysfunction-associated steatohepatitis+1

A Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety

Metabolic dysfunction-associated steatohepatitis+1

A Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis

Chronic spontaneous urticaria

A study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria

Pancreatic neuroendocrine tumour

A study comparing XL092 versus everolimus in patients with previously treated advanced or metastatic neuroendocrine tumors

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.